Pharmacogenetic Testing: The Ethics of Implementing in Clinical Practice for Chronic Pain Patients

References

• Global Industry Analysts, Inc. Report, January 10, 2011. http://www.prweb.com/pdfdownload/8052240.pdf. Accessed February 11, 2019.
   Google Scholar
• Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education: Relieving Pain in America, A Blueprint for Transforming Prevention, Care, Education and Research. The National Academies Press, 2011. http://books.nap.edu/openbook.php?record_id=13172&page=1. Accessed February 11, 2019.
   Google Scholar
• Schildcrout JS, Denny JC, Bowton E, et al. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther. 2012;92(2):235–242. doi:10.1038/clpt.2012.66.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Traitement de la douleur cancereuse. Geneva, Switz: World Health Organization, 1987.
   Google Scholar
• Ting S, Schug S. The pharmacogenomics of pain management: prospects for personalized medicine. J Pain Res. 2016;9:49–56. doi:10.2147/JPR.S55595.
   PubMed Web of Science ®Google Scholar
• Lundqvist C, Gossop M, Russell MB, et al. Severity of analgesic dependence and medication-overuse headache. J. Addiction Med. 2019;13(5):346–353. doi:10.1097/ADM.0000000000000504.
   PubMed Web of Science ®Google Scholar
• Owusu Obeng A, Hamadeh I, Smith M. Review of opioid pharmacogenetics and considerations for pain management. Pharmacother. 2017;37(9):1105–1121. doi:10.1002/phar.1986.
   PubMed Web of Science ®Google Scholar
• Agarwal D, Udoji MA, Trescot A. Genetic testing for opioid pain management: A primer. Pain Ther. 2017;6(1):93–105. doi:10.1007/s40122-017-0069-2.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ingelman‐Sundberg M, Lauschke VM. Worldwide distribution of cytochrome P450 alleles: a meta‐analysis of population‐scale sequencing projects. Clin Pharmacol Ther. 2017;102(4):688–700. doi:10.1002/cpt.690.
   PubMed Web of Science ®Google Scholar
• Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–350. doi:10.1038/nature15817.
   PubMed Web of Science ®Google Scholar
• Roden DM, Van Driest SL, Mosley JD, et al. Benefit of preemptive pharmacogenetic information on clinical outcome. Clin Pharmacol Ther. 2018;103(5):787–794. doi:10.1002/cpt.1035.
   PubMed Web of Science ®Google Scholar
• Ko TM, Wong CS, Wu JY, et al. Pharmacogenomics for personalized pain medicine. Acta Anaesthesiol Taiwan. 2016;54(1):24–30. doi:10.1016/j.aat.2016.02.001.
   PubMedGoogle Scholar
• Sekhri NK, Cooney MF. Opioid metabolism and pharmacogenetics: Clinical implications. J PeriAnesthe Nursing. 2017;32(5):497–505. doi:10.1016/j.jopan.2017.07.005.
   PubMed Web of Science ®Google Scholar
• Goh LL, Lim CW, Sim WC, et al. Analysis of genetic variation in CYP450 genes for clinical implementation. PloS one. 2017;12(1):e0169233. doi:10.1371/journal.pone.0169233.
   PubMed Web of Science ®Google Scholar
• Huddart R, Fohner AE, Whirl‐Carrillo M, et al. Standardized biogeographic grouping system for annotating populations in pharmacogenetic research. Clin Pharmacol Ther. 2019;105(5):1256–1262. doi:10.1002/cpt.1322.
   PubMed Web of Science ®Google Scholar
• Relling MV, Klein TE. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011;89(3):464–467. doi:10.1038/clpt.2010.279.
   PubMed Web of Science ®Google Scholar
• Bielinski SJ, Olson JE, Pathak J, et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time—using genomic data to individualize treatment protocol. Mayo Clin Proceed. 2014;89(1):25–33. Elsevier. doi:10.1016/j.mayocp.2013.10.021.
   Google Scholar
• Vogel F. Moderne Probleme der Humangenetik. Ergeb Inn Med Kinderheilk. 1959;12:52–125.
   Google Scholar
• Pirmohamed M. Pharmacogenetics and pharmacogenomics. Br J Clin Pharmacol. 2001;52(4):345–347. PMC 2014592 . PMID 11678777.
   PubMed Web of Science ®Google Scholar
• Squassina A, Manchia M, Manolopoulos VG, et al. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogen. 2010;11(8):1149–1167. doi:10.2217/pgs.10.97.
   Google Scholar
• Schuck RN, Marek E, Rogers H, et al. Clinical and regulatory considerations in pharmacogenetic testing. Am J Health-Syst Pharm. 2016;73(23):1999–2006. doi:10.2146/ajhp160476.
   PubMed Web of Science ®Google Scholar
• Caudle KE, Keeling NJ, Klein TE, et al. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. Pharmacogen. 2018;19(10):847–860. doi:10.2217/pgs-2018-0028.
   Google Scholar
• Nucleic Acid Based Tests. U. S. Food & Drug Administration. 2019. https://www.fda.gov/Medical Devices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm330711.htm. Accessed February 11, 2019.
   Google Scholar
• FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism. FDA news release. 2018. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm6 24753.htm. Accessed February 11, 2019.
   Google Scholar
• Shuren J. M.D., J.D., director of the FDA’s Center for Devices and Radiological Health and Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research on agency’s warning to consumers about genetic tests that claim to predict patients’ responses to specific medications. FDA Statement. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624794.htm. Accessed February 11, 2019.
   Google Scholar
• AMP comments genetic test results FDA 2015-N-4809. 2015. https://www.amp.org/AMP/assets/File/position-statements/2016/AMPcomments-genetictestresults-FDA-2 015-N-4809-FINAL.pdf?pass=52. Accessed August 6, 2019.
   Google Scholar
• Wueste DE. Biomedical Ethics. In Encyclopedia of Biomaterials and Biomedical Engineering (Chapter 9). London, UK: Taylor & Francis Group; 2006;1–9.
   Google Scholar
• Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Personalized Med. 2015;12(1):43–51. doi:10.2217/pme.14.65.
   PubMed Web of Science ®Google Scholar
• Brown LC, Lorenz RA, Li J, et al. Economic utility: combinatorial pharmacogenomics and medication cost savings for mental health care in a primary care setting. Clin Therap. 2017;39(3):592–602. doi:10.1016/j.clinthera.2017.01.022.
   PubMed Web of Science ®Google Scholar
• Dong OM, Wiltshire T. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting. Physiol Genom. 2017;49(7):346–354. doi:10.1152/physiolgenomics.00029.2017.
   PubMed Web of Science ®Google Scholar
• Johnson JA, Caudle KE, Gong L, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update. Clin Pharmacol Ther. 2017;102(3):397–404. doi:10.1002/cpt.668.
   PubMed Web of Science ®Google Scholar
• Health Insurance Portability and Accountability Act. Pub. L. No. 104-191, § 264, 110 Stat1936. 2017. https://www.hhs.gov/hipaa/for-professionals/index.html. Accessed August 6, 2019.
   Google Scholar
• Bielinski SJ, St Sauver JL, Olson JE, et al. Are patients willing to incur out-of-pocket costs for pharmacogenomic testing? Pharmacogenomics J. 2017;17(1):1–3. doi:10.1038/tpj.2016.72.
   PubMed Web of Science ®Google Scholar
• Chambliss AB, Marzinke MA. Clinical pharmacogenetics for precision medicine: Successes and setbacks. J App Lab Med. 2018;3(3):474–486. doi:10.1373/jalm.2017.023127.
   Google Scholar
• Haga SB, Mills R, Moaddeb J, et al. Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenom. 2016;17(15):1629–1636. doi:10.2217/pgs-2016-0077.
   PubMed Web of Science ®Google Scholar
• Shields AE. Ethical concerns related to developing pharmacogenomic treatment strategies for addiction. Addic Sci Clin Pract. 2011;6(1):32–43.
   PubMedGoogle Scholar
• Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–780. doi:10.1016/j.jpain.2015.05.002.
   PubMed Web of Science ®Google Scholar